76 related articles for article (PubMed ID: 21761205)
1. Protein kinase CK2: a catalyst for biology, medicine and structural biochemistry.
Ahmed K; Issinger OG; Niefind K
Mol Cell Biochem; 2011 Oct; 356(1-2):1-3. PubMed ID: 21761205
[No Abstract] [Full Text] [Related]
2. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling.
Heiker JT; Wottawah CM; Juhl C; Kosel D; Mörl K; Beck-Sickinger AG
Cell Signal; 2009 Jun; 21(6):936-42. PubMed ID: 19233263
[TBL] [Abstract][Full Text] [Related]
3. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
Raaf J; Brunstein E; Issinger OG; Niefind K
Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
[TBL] [Abstract][Full Text] [Related]
4. Antitumor activity of pyridocarbazole and benzopyridoindole derivatives that inhibit protein kinase CK2.
Prudent R; Moucadel V; Nguyen CH; Barette C; Schmidt F; Florent JC; Lafanechère L; Sautel CF; Duchemin-Pelletier E; Spreux E; Filhol O; Reiser JB; Cochet C
Cancer Res; 2010 Dec; 70(23):9865-74. PubMed ID: 21118972
[TBL] [Abstract][Full Text] [Related]
5. CK2 activity is modulated by growth rate in Saccharomyces cerevisiae.
Tripodi F; Cirulli C; Reghellin V; Marin O; Brambilla L; Schiappelli MP; Porro D; Vanoni M; Alberghina L; Coccetti P
Biochem Biophys Res Commun; 2010 Jul; 398(1):44-50. PubMed ID: 20599749
[TBL] [Abstract][Full Text] [Related]
6. [Protein kinase CK2 and human malignant tumors].
Huang Y; Zhou S; Xue H; Zhao Z; Wang L
Zhongguo Fei Ai Za Zhi; 2012 Jul; 15(7):439-45. PubMed ID: 22814265
[No Abstract] [Full Text] [Related]
7. Inhibition of protein kinase CK2 induces E2F1 nuclear export, formation of p21/E2F1 complexes and suppression of DNA synthesis in normal human epidermal keratinocytes.
Isaeva AR; Mitev VI
J Dermatol Sci; 2009 Aug; 55(2):134-6. PubMed ID: 19409758
[No Abstract] [Full Text] [Related]
8. Resorufin: a lead for a new protein kinase CK2 inhibitor.
Sandholt IS; Olsen BB; Guerra B; Issinger OG
Anticancer Drugs; 2009 Apr; 20(4):238-48. PubMed ID: 19177021
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and proapoptotic properties of new casein kinase II inhibitors.
Koronkiewicz M; Zukowska M; Chilmonczyk Z; Orzeszko A; Kazimierczuk Z
Acta Pol Pharm; 2010; 67(6):635-41. PubMed ID: 21229880
[TBL] [Abstract][Full Text] [Related]
10. New protein kinase CK2 inhibitors: jumping out of the catalytic box.
Prudent R; Cochet C
Chem Biol; 2009 Feb; 16(2):112-20. PubMed ID: 19246001
[TBL] [Abstract][Full Text] [Related]
11. Cellular regulators of protein kinase CK2.
Montenarh M
Cell Tissue Res; 2010 Nov; 342(2):139-46. PubMed ID: 20976471
[TBL] [Abstract][Full Text] [Related]
12. [Polyoxometalates. A new class of inorganic CK2 inhibitors].
Prudent R; Hasenknopf B; Cochet C
Med Sci (Paris); 2008 Dec; 24(12):1012-4. PubMed ID: 19116103
[No Abstract] [Full Text] [Related]
13. Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2.
Nie Z; Perretta C; Erickson P; Margosiak S; Almassy R; Lu J; Averill A; Yager KM; Chu S
Bioorg Med Chem Lett; 2007 Aug; 17(15):4191-5. PubMed ID: 17540560
[TBL] [Abstract][Full Text] [Related]
14. Casein Kinase II: an attractive target for anti-cancer drug design.
Hanif IM; Hanif IM; Shazib MA; Ahmad KA; Pervaiz S
Int J Biochem Cell Biol; 2010 Oct; 42(10):1602-5. PubMed ID: 20558317
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids as inhibitors of human protein kinase CK2.
Golub AG; Bdzhola VG; Briukhovetska NV; Balanda AO; Kukharenko OP; Kotey IM; Ostrynska OV; Yarmoluk SM
Eur J Med Chem; 2011 Mar; 46(3):870-6. PubMed ID: 21276643
[TBL] [Abstract][Full Text] [Related]
16. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T
Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254
[TBL] [Abstract][Full Text] [Related]
17. Casein kinase II inhibition induces apoptosis in pancreatic cancer cells.
Hamacher R; Saur D; Fritsch R; Reichert M; Schmid RM; Schneider G
Oncol Rep; 2007 Sep; 18(3):695-701. PubMed ID: 17671722
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
Najda-Bernatowicz A; Łebska M; Orzeszko A; Kopańska K; Krzywińska E; Muszyńska G; Bretner M
Bioorg Med Chem; 2009 Feb; 17(4):1573-8. PubMed ID: 19168362
[TBL] [Abstract][Full Text] [Related]
19. Critical role for casein kinase 2 and phosphoinositide-3-kinase in the interferon-gamma-induced expression of monocyte chemoattractant protein-1 and other key genes implicated in atherosclerosis.
Harvey EJ; Li N; Ramji DP
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):806-12. PubMed ID: 17255531
[TBL] [Abstract][Full Text] [Related]
20. The dark side of protein kinase CK2 inhibition.
Cozza G; Meggio F; Moro S
Curr Med Chem; 2011; 18(19):2867-84. PubMed ID: 21651492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
